Carvana (NYSE:CVNA – Free Report) had its price target lowered by Evercore ISI from $250.00 to $240.00 in a report issued on ...

Investors have been cautious about high-growth technology stocks in 2024, with broader market uncertainty and concerns over President Donald Trump’s tariff policies putting pressure on valuations. The ...

M&T Bank (NYSE:MTB – Free Report) had its price target trimmed by Evercore ISI from $234.00 ... which can be accessed through the SEC website. Company insiders own 0.53% of the company’s ...

Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea ...

Kyle Walters, a private equity analyst at PitchBook, pointed out that sponsoring all these sports can be quite expensive, and ...

Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea ...

Q4 2024 Earnings Call Transcript March 6, 2025 Atea Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is ...

Paratek will accelerate access for XHANCE beyond specialists to primary care providers maximizing the recent label expansion for CRS in a ...

EY believes that utilities are required to balance growing energy demands, decarbonization goals and customer satisfaction while, at the same time, navigating regulatory and financial challenges.

SMG Swiss Marketplace Group AG, which operates online real estate website ImmoScout24, has picked banks for an initial public ...

Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic ...